title: Preservation of retroperitoneal lymph nodes in patients with locoregional nonseminomatous germ cell tumors: surveillance and primary chemotherapy.
authors.affiliation: Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: A C
authors.initials: AC
authors.lastname: von Eschenbach
authors.forename: D A
authors.initials: DA
authors.lastname: Swanson
authors.forename: D E
authors.initials: DE
authors.lastname: Johnson
authors.forename: K I
authors.initials: KI
authors.lastname: Wishnow
authors.forename: R A
authors.initials: RA
authors.lastname: Stephenson
authors.forename: R J
authors.initials: RJ
authors.lastname: Babaian
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000628:therapy*; D010537:Peritoneum; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin